Furthermore, addition of caffeine or Idelalisib to activated CLL cells significantly inhibited phosphorylation of AKT, a downstream kinase of PI3K, but did not affect CLL viability. This evidence concerns the gene AKT1 and B-cell chronic lymphocytic leukemia.